User profiles for "author:S E Smith"
Sarah E SmithMestag Therapeutics Verified email at mestagtx.com Cited by 1911 |
Roles of arbuscular mycorrhizas in plant nutrition and growth: new paradigms from cellular to ecosystem scales
SE Smith, FA Smith - Annual review of plant biology, 2011 - annualreviews.org
Root systems of most land plants form arbuscular mycorrhizal (AM) symbioses in the field,
and these contribute to nutrient uptake. AM roots have two pathways for nutrient absorption …
and these contribute to nutrient uptake. AM roots have two pathways for nutrient absorption …
Roles of arbuscular mycorrhizas in plant phosphorus nutrition: interactions between pathways of phosphorus uptake in arbuscular mycorrhizal roots have important …
SE Smith, I Jakobsen, M Grønlund, FA Smith - Plant physiology, 2011 - academic.oup.com
In this Update, we review new findings about the roles of the arbuscular mycorrhizas
(mycorrhiza= fungus plus root) in plant growth and phosphorus (P) nutrition. We focus …
(mycorrhiza= fungus plus root) in plant growth and phosphorus (P) nutrition. We focus …
Plant nutrient-acquisition strategies change with soil age
Nitrogen (N) tends to limit plant productivity on young soils; phosphorus (P) becomes
increasingly limiting in ancient soils because it gradually disappears through leaching and …
increasingly limiting in ancient soils because it gradually disappears through leaching and …
[BOOK][B] Mycorrhizal symbiosis
SE Smith, DJ Read - 2010 - books.google.com
The roots of most plants are colonized by symbiotic fungi to form mycorrhiza, which play a
critical role in the capture of nutrients from the soil and therefore in plant nutrition …
critical role in the capture of nutrients from the soil and therefore in plant nutrition …
[HTML][HTML] Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma
A Younes, AK Gopal, SE Smith, SM Ansell… - Journal of clinical …, 2012 - ncbi.nlm.nih.gov
Purpose Brentuximab vedotin is an antibody-drug conjugate (ADC) that selectively delivers
monomethyl auristatin E, an antimicrotubule agent, into CD30-expressing cells. In phase I …
monomethyl auristatin E, an antimicrotubule agent, into CD30-expressing cells. In phase I …
[HTML][HTML] IFITM3 restricts the morbidity and mortality associated with influenza
The 2009 H1N1 influenza pandemic showed the speed with which a novel respiratory virus
can spread and the ability of a generally mild infection to induce severe morbidity and …
can spread and the ability of a generally mild infection to induce severe morbidity and …
Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association
BS Marino, PH Lipkin, JW Newburger, G Peacock… - Circulation, 2012 - Am Heart Assoc
Background—The goal of this statement was to review the available literature on
surveillance, screening, evaluation, and management strategies and put forward a scientific …
surveillance, screening, evaluation, and management strategies and put forward a scientific …
Plant and microbial strategies to improve the phosphorus efficiency of agriculture
Background Agricultural production is often limited by low phosphorus (P) availability. In
developing countries, which have limited access to P fertiliser, there is a need to develop …
developing countries, which have limited access to P fertiliser, there is a need to develop …
Mycorrhizal fungi can dominate phosphate supply to plants irrespective of growth responses
SE Smith, FA Smith, I Jakobsen - Plant physiology, 2003 - academic.oup.com
Arbuscular mycorrhizal (AM) fungi are vital components of nearly all terrestrial ecosystems,
forming mutually beneficial (mutualistic) symbioses with the roots of around 80% of vascular …
forming mutually beneficial (mutualistic) symbioses with the roots of around 80% of vascular …
[HTML][HTML] Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL
JA Woyach, AS Ruppert, NA Heerema… - … England Journal of …, 2018 - Mass Medical Soc
Background Ibrutinib has been approved by the Food and Drug Administration for the
treatment of patients with untreated chronic lymphocytic leukemia (CLL) since 2016 but has …
treatment of patients with untreated chronic lymphocytic leukemia (CLL) since 2016 but has …